Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer ’s pathology
ConclusionsThe AM –NP nanotechnology presents a multifactorial strategy to target pathological Aβ aggregation and arrest the fAβ-mediated pathological progression in microglia and neurons.Graphical Abstract
Source: Translational Neurodegeneration - Category: Neurology Source Type: research
More News: Alzheimer's | Brain | Nanotechnology | Neuroblastoma | Neurology | Pathology | Study | Sugar